Avelumab plus axitinib for translocation renal cell carcinoma: A case series and literature review
Kenta Takahashi,
Renpei Kato,
Daiki Ikarashi
et al.
Abstract:IntroductionPatients with translocation renal cell carcinoma (tRCC) have a poor prognosis without standardized treatment.Case presentationThe first case was of a 72‐year‐old woman who underwent robot‐assisted partial nephrectomy for a left renal tumor and was pathologically diagnosed with tRCC. Recurrence was observed in the left retroperitoneal soft tissue. After treatment with avelumab–axitinib, continued progression‐free survival was confirmed at the 90‐week follow‐up. The second case was of a 41‐year‐old w… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.